Compare LYEL & CAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LYEL | CAN |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 490.1M | 486.0M |
| IPO Year | 2021 | 2019 |
| Metric | LYEL | CAN |
|---|---|---|
| Price | $23.20 | $0.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $30.60 | $3.21 |
| AVG Volume (30 Days) | 79.7K | ★ 8.3M |
| Earning Date | 05-12-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16,285.34 | $63.64 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.39 | $0.39 |
| 52 Week High | $45.00 | $2.22 |
| Indicator | LYEL | CAN |
|---|---|---|
| Relative Strength Index (RSI) | 55.91 | 60.34 |
| Support Level | $21.27 | $0.43 |
| Resistance Level | $27.30 | $0.55 |
| Average True Range (ATR) | 1.70 | 0.03 |
| MACD | 0.53 | 0.01 |
| Stochastic Oscillator | 75.83 | 89.72 |
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.